ORASURE TECHNOLOGIES, INC Amortization of Intangible Assets
ORASURE TECHNOLOGIES, INC (OSUR) reported Amortization of Intangible Assets of $300.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-09.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:AmortizationOfIntangibleAssets · last filed 2026-03-09
- ORASURE TECHNOLOGIES, INC amortization of intangible assets for the quarter ending 2022-12-31 was $683.00K, a 19.17% decline year-over-year.
- ORASURE TECHNOLOGIES, INC amortization of intangible assets for the quarter ending 2022-09-30 was $497.00K, a 38.79% decline year-over-year.
- ORASURE TECHNOLOGIES, INC amortization of intangible assets for the quarter ending 2022-06-30 was $552.00K, a 33.57% decline year-over-year.
- ORASURE TECHNOLOGIES, INC amortization of intangible assets for the quarter ending 2022-03-31 was $568.00K, a 30.05% decline year-over-year.
- ORASURE TECHNOLOGIES, INC amortization of intangible assets for fiscal 2025 was $300.00K, a 57.14% decline from fiscal 2024.
- ORASURE TECHNOLOGIES, INC amortization of intangible assets for fiscal 2024 was $700.00K, a 65.00% decline from fiscal 2023.
- ORASURE TECHNOLOGIES, INC amortization of intangible assets for fiscal 2023 was $2.00M, a 13.04% decline from fiscal 2022.
- ORASURE TECHNOLOGIES, INC amortization of intangible assets for fiscal 2022 was $2.30M, a 30.30% decline from fiscal 2021.
| Period end | Amortization of Intangible Assets 3 month | Amortization of Intangible Assets 6 month | Amortization of Intangible Assets 9 month | Amortization of Intangible Assets 12 month | Amortization of Intangible Assets 12 month as first filed |
|---|---|---|---|---|---|
| 2025-12-31 | $300.00K 10-K · filed 2026-03-09 | ||||
| 2024-12-31 | $700.00K 10-K · filed 2026-03-09 | ||||
| 2023-12-31 | $2.00M 10-K · filed 2026-03-09 | ||||
| 2022-12-31 | $683.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-07 | $1.18M derived: sum of 2 quarters · filed 2025-03-07 | $1.73M derived: sum of 3 quarters · filed 2025-03-07 | $2.30M 10-K · filed 2025-03-07 | $2.27M 10-K · filed 2023-03-03 |
| 2022-09-30 | $497.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | $1.05M derived: sum of 2 quarters · filed 2022-11-08 | $1.62M 10-Q · filed 2022-11-08 | $2.46M derived: sum of 4 quarters · filed 2024-03-11 | |
| 2022-06-30 | $552.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | $1.12M 10-Q · filed 2022-08-09 | $1.97M derived: sum of 3 quarters · filed 2024-03-11 | $2.78M derived: sum of 4 quarters · filed 2024-03-11 | |
| 2022-03-31 | $568.00K 10-Q · filed 2022-05-10 | $1.41M derived: sum of 2 quarters · filed 2024-03-11 | $2.23M derived: sum of 3 quarters · filed 2024-03-11 | $3.06M derived: sum of 4 quarters · filed 2024-03-11 | |
| 2021-12-31 | $845.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-11 | $1.66M derived: sum of 2 quarters · filed 2024-03-11 | $2.49M derived: sum of 3 quarters · filed 2024-03-11 | $3.30M 10-K · filed 2024-03-11 | $3.26M 10-K · filed 2022-03-01 |
| 2021-09-30 | $812.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | $1.64M derived: sum of 2 quarters · filed 2021-11-04 | $2.46M 10-Q · filed 2021-11-04 | $3.34M derived: sum of 4 quarters · filed 2023-03-03 | |
| 2021-06-30 | $831.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | $1.64M 10-Q · filed 2021-08-05 | $2.53M derived: sum of 3 quarters · filed 2023-03-03 | $3.36M derived: sum of 4 quarters · filed 2023-03-03 | |
| 2021-03-31 | $812.00K 10-Q · filed 2021-05-06 | $1.70M derived: sum of 2 quarters · filed 2023-03-03 | $2.53M derived: sum of 3 quarters · filed 2023-03-03 | $3.33M derived: sum of 4 quarters · filed 2023-03-03 | |
| 2020-12-31 | $885.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-03 | $1.72M derived: sum of 2 quarters · filed 2023-03-03 | $2.51M derived: sum of 3 quarters · filed 2023-03-03 | $3.25M 10-K · filed 2023-03-03 | |
| 2020-09-30 | $834.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $1.63M derived: sum of 2 quarters · filed 2020-11-05 | $2.36M 10-Q · filed 2020-11-05 | ||
| 2020-06-30 | $795.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | $1.53M 10-Q · filed 2020-08-06 | |||
| 2020-03-31 | $732.00K 10-Q · filed 2020-05-11 | ||||
| 2019-12-31 | $2.52M 10-K · filed 2022-03-01 | ||||
| 2019-06-30 | $615.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-07 | $1.23M 10-Q · filed 2019-08-07 | $1.84M derived: sum of 3 quarters · filed 2021-03-01 | $2.53M derived: sum of 4 quarters · filed 2021-03-01 | |
| 2019-03-31 | $613.00K 10-Q · filed 2019-05-09 | $1.23M derived: sum of 2 quarters · filed 2021-03-01 | $1.91M derived: sum of 3 quarters · filed 2021-03-01 | $2.57M derived: sum of 4 quarters · filed 2021-03-01 | |
| 2018-12-31 | $614.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | $1.30M derived: sum of 2 quarters · filed 2021-03-01 | $1.96M derived: sum of 3 quarters · filed 2021-03-01 | $2.62M 10-K · filed 2021-03-01 | |
| 2018-09-30 | $685.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | $1.34M derived: sum of 2 quarters · filed 2018-11-08 | $2.01M 10-Q · filed 2018-11-08 | $2.67M derived: sum of 4 quarters · filed 2020-03-02 | |
| 2018-06-30 | $660.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | $1.32M 10-Q · filed 2018-08-09 | $1.98M derived: sum of 3 quarters · filed 2020-03-02 | $2.67M derived: sum of 4 quarters · filed 2020-03-02 | |
| 2018-03-31 | $664.00K 10-Q · filed 2018-05-09 | $1.32M derived: sum of 2 quarters · filed 2020-03-02 | $2.01M derived: sum of 3 quarters · filed 2020-03-02 | $2.67M derived: sum of 4 quarters · filed 2020-03-02 | |
| 2017-12-31 | $657.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-02 | $1.35M derived: sum of 2 quarters · filed 2020-03-02 | $2.00M derived: sum of 3 quarters · filed 2020-03-02 | $2.64M 10-K · filed 2020-03-02 | |
| 2017-09-30 | $689.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | $1.35M derived: sum of 2 quarters · filed 2017-11-09 | $1.98M 10-Q · filed 2017-11-09 | $2.06M derived: sum of 4 quarters · filed 2019-02-28 | |
| 2017-06-30 | $658.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09 | $1.29M 10-Q · filed 2017-08-09 | $1.37M derived: sum of 3 quarters · filed 2019-02-28 | ||
| 2017-03-31 | $637.00K 10-Q · filed 2017-05-09 | $708.00K derived: sum of 2 quarters · filed 2019-02-28 | |||
| 2016-12-31 | $71.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-28 | $2.54M 10-K · filed 2019-02-28 | |||
| 2016-09-30 | $2.47M 10-Q · filed 2016-11-08 | ||||
| 2015-12-31 | $2.70M 10-K · filed 2018-02-28 | ||||
| 2014-12-31 | $3.18M 10-K · filed 2017-03-14 | ||||
| 2013-12-31 | $3.53M 10-K · filed 2016-03-14 | ||||
| 2012-12-31 | $3.90M 10-K · filed 2015-03-12 | ||||
| 2011-12-31 | $1.96M 10-K · filed 2014-03-14 | ||||
| 2010-12-31 | $502.00K 10-K · filed 2013-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |